Leavell Investment Management, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Leavell Investment Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 20, 2022	SELL	$543.48 - $670.97 $1.21 Million - $1.5 Million	-2,235 Closed	0 $0
Q3 2021 Oct 26, 2021	BUY	$574.03 - $680.96 $708,927 - $840,985	1,235 Added 123.5%	2,235 $1.35 Million
Q2 2018 Jul 23, 2018	SELL	$284.6 - $344.99 $247,602 - $300,141	-870 Reduced 46.52%	1,000 $345,000
Q3 2017 Oct 25, 2017	BUY	$431.38 - $504.0 $806,680 - $942,480	1,870	1,870 $836,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Leavell Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Leavell Investment Management, Inc. with notifications on news.